澳大利亚 TGA 路径与检测报告采信

结论：能不能少做事，取决于你手上已有什么

澳大利亚的一个特点是：在一定条件下可以采信境外的符合性评估结果。 对已经在欧盟或其他市场完成评估的企业，这意味着可以节省相当一部分工作。

但采信不是自动的，有条件和范围限制。所以准备的第一步是判断：你手上的材料属不属于可以被采信的类型，覆盖范围够不够。

判断错了会走弯路：以为能采信而没准备完整证据，或者以为不能采信而重做了一遍。

采信的基本条件

可被采信的证据通常需要满足几点：

出具方的资质被认可。 不是任何机构出具的评估结果都被接受。

覆盖范围匹配。 评估覆盖的产品范围要包含你申请的产品，不能有实质性差异。

时效性。 证书或评估结果在有效期内。

产品未发生实质变更。 评估之后产品若有变更，需要评估变更的影响。

即使采信成立，仍需要提交产品的技术信息，只是审查深度不同。所以检测数据仍然要有，只是可能不必重新做。

分级与证据深度

注意「留存备查」不等于不需要。 较低级别的产品虽然提交的材料少，但技术文件仍须保存完整，监管方可以随时要求提供。实际中有企业理解成低级别不用做检测，这是误解。

检测证据的准备

无论是否采信境外结果，以下内容都应当具备：

产品性能数据。 对应产品标准或自定技术要求的实测结果。

安全相关数据。 电气安全、机械安全等适用项。

生物相容性。 按接触性质与时间确定的项目。

灭菌与包装。 无菌产品适用。

软件验证。 含软件的产品适用。

这些数据如果是为其他市场做的，多数可以直接使用，前提是方法标准被认可、报告内容完整。

语言与格式

提交材料需要英文。如果原报告是中文，需要处理翻译，并注意翻译的准确性说明。

更省事的做法是在委托检测时就要求英文报告。 这一点如果提前规划，几乎不增加成本；报告出来之后再补，等同于重新出具。

常见的准备遗漏

赞助商（本地责任主体）的安排。 申请需要由本地主体提出，这个安排要提前落实。

产品分类判断。 分类影响证据要求，判断错会导致准备不足。

技术文件的完整性。 即使走采信路径，技术文件仍要完整保存，以备检查。

变更的跟踪。 采信基于某个时点的评估结果，之后产品变更要评估影响。

标签与说明书的本地要求。 内容与格式要符合当地要求，且与检测数据一致。

上市后的义务

获得登记之后，还有持续的义务：不良事件报告、产品变更通知、定期的信息更新。

与检测相关的是：产品变更时要判断是否影响已提交或已采信的证据。如果变更影响了安全有效性，可能需要补充数据甚至重新评估。

建议把这个判断纳入变更评审流程，与其他市场的变更评估一起做，避免各市场分别遗漏。

与其他市场的协同

如果产品面向多个市场，建议这样组织：

先按要求较严的市场准备完整的技术文件和检测数据；再针对各市场的程序要求做补充；能采信的市场利用采信节省评估环节；语言上统一用英文准备主文件，需要时再翻译成其他语言。

这个顺序能把重复工作降到较低水平。 反过来，先做要求较松的市场再补，往往要重新送检。

临床证据与检测数据的关系

有些产品除了检测数据，还需要临床方面的证据。两者的关系是：检测数据证明产品的物理、化学、生物学特性符合要求；临床证据证明产品在预期用途下安全有效。

检测数据不能替代临床证据，但可以减少临床证据的需求量。 如果产品与已上市产品在技术特征上高度一致，并且检测数据能证明这种一致性，那么可以更多依赖已有的临床数据而不必重新做临床。

所以从策略上说，把与对比产品的技术等同性证明做扎实，是降低临床举证负担的有效路径。 这部分工作的核心就是检测数据——同样的方法、同样的条件，把自己的产品和对比产品放在一起测，差异才说得清楚。

申请前的自查

正式提交之前，建议按以下几条自查一遍：

产品分类的判断依据写下来了没有；适用标准清单是否完整，有没有漏掉适用项；每个标准对应的检测数据是否齐全，报告是否在有效期内；样品信息（批号、生产日期、生产场地）是否与技术文件一致；说明书和标签里出现的技术参数，是否都能在检测报告里找到对应值；若走采信路径，被采信的证据是否覆盖了申请范围；技术文件是否完整保存并可随时调取。

其中「说明书参数与检测数据对应」这一条最容易出问题，因为说明书通常由市场或技术部门起草，与检测环节脱节。建议提交前做一次逐项核对。

我们的做法

承接面向澳大利亚的委托时，我们会先问一句：产品是否已经在其他市场完成过评估、有没有现成的报告。如果有，很多项目不必重做，我们只需要评估现有报告的覆盖范围并补差额。

对于需要英文报告的委托，建议在委托阶段提出，我们直接出具英文或中英对照版本。这比事后翻译更可靠，也避免了翻译准确性的额外举证。

如果你在准备澳大利亚市场的申请，不确定现有材料够不够，可以把现有报告和产品资料发过来一起评估，或者直接联系：132 4819 8029。能力范围见服务介绍，送检要求见送检要求，流程见检测流程。

English version

Conclusion. A distinctive feature of the Australian framework is that conformity assessment evidence from certain overseas sources may be accepted. For manufacturers who have already completed assessment for the European or other markets, that can save a substantial amount of work. Acceptance is not automatic, however, and comes with conditions and limits of scope. The first step is therefore judging whether what you hold is of a type that can be relied upon and whether its coverage is adequate. Getting that judgement wrong wastes effort in either direction: assuming acceptance and preparing incomplete evidence, or assuming the opposite and repeating work unnecessarily.

Conditions for acceptance. The issuing body's standing must be recognised, since not every organisation's output is accepted. Coverage must match, with the assessed product range encompassing what you are applying for and no substantive difference. The evidence must be current. And the product must not have changed substantively since assessment; where it has, the effect of the change must be evaluated. Even where acceptance applies, product technical information must still be submitted; only the depth of review differs. Test data are therefore still required, they simply may not need repeating.

Classification and depth of evidence. At lower risk levels, a manufacturer declaration predominates with technical documentation retained for inspection. At intermediate levels, conformity assessment evidence including test data is required. At higher levels, complete technical documentation faces deeper review. Note that retained for inspection does not mean not required: lower-class products submit less while still having to hold complete technical files, which regulators may call for at any time. Some manufacturers read low class as meaning no testing is needed, which is a misunderstanding.

Evidence to have available. Regardless of whether overseas results are accepted, you should hold performance data against the product standard or your own technical requirements; safety data for applicable electrical and mechanical aspects; biocompatibility appropriate to contact nature and duration; sterilisation and packaging evidence for sterile products; and software verification where software is present. Where these were generated for another market they can generally be used directly, provided the method standard is recognised and the report is complete.

Language and format. Submissions require English. Where the original report is in Chinese, translation must be handled and its accuracy may need to be addressed. Requesting an English report when commissioning the testing is far simpler: planned in advance it adds almost nothing to cost, while adding it afterwards amounts to reissuing the report.

Frequent omissions. Arranging the local responsible entity, since the application must come from one and this needs settling early. Product classification, which drives evidence requirements and leads to under-preparation when misjudged. Completeness of the technical file, which must be retained in full even where the acceptance route is used. Tracking changes, since acceptance rests on an assessment at a point in time and subsequent changes need evaluating. And local labelling and instruction requirements, which must meet local expectations and agree with the test data.

Post-market obligations. After listing, obligations continue: adverse event reporting, notification of product changes, and periodic updates. On the testing side, product changes require judging whether previously submitted or accepted evidence is affected; where safety or performance is affected, supplementary data or reassessment may be needed. Build that judgement into the change review process alongside assessments for other markets, so that no market is overlooked.

Coordinating across markets. Prepare a complete technical file and test data to the strictest market first; add what each market's procedures require; use acceptance where available to save the assessment step; and prepare the master file in English, translating where needed. That order minimises duplicated work, whereas starting with the least demanding market and adding later usually means submitting samples again.

How we handle it. For Australian work we ask first whether the product has already been assessed elsewhere and what reports exist. Where they do, much need not be repeated and we simply assess coverage and address the difference. Where an English report is needed we suggest saying so when commissioning, so we can issue in English or bilingually, which is more reliable than later translation and avoids having to demonstrate translation accuracy.

Send us your existing reports and product information and we will assess what is still needed. Phone or WeChat: +86 132 4819 8029.